Skip to main content

Table 2 Clinical characteristics of patients with COVID-19 on admission

From: Risk factors for disease progression in COVID-19 patients

VariableTotalCured GroupTransferred GroupP-value
Total, n (%)211 (100%)198 (93.8%)13 (6.2%) 
Age, years37.55 ± 14.5336.47 ± 14.0454.08 ± 11.98.000*
Sex, n (%)
 Female137 (64.9%)129 (65.2%)8 (61.5%).791
 Male74 (35.1%)69 (34.8%)5 (38.5%)
Initial vital sign & symptoms
 Body temperature (°C)37.09 ± 4.8537.04 ± 0.4237.81 ± 0.76.003*
 Oxygen saturation (%)97.20 ± 11.8897.24 ± 11.9396.57 ± 9.76.096
 Chills22 (10.4%)16 (8.1%)6 (46.2%).000*
 Cough92 (43.6%)83 (41.9%)9 (69.2%).054
 Myalgia44 (20.9%)35 (17.7%)9 (69.2%).000*
 Sputum66 (31.3%)59 (29.8%)7 (53.8%).070
 Rhinorrhea58 (27.5%)52 (26.3%)6 (46.2%).120
 Sore throat46 (21.8%)43 (21.7%)3 (23.1%).908
 Headache53 (25.1%)47 (23.7%)6 (46.2%).071
 Diarrhea33 (15.6%)30 ((1.5%)3 (23.1%).446
 Dyspnea26 (12.3%)21 (10.6%)5 (38.5%).003*
 Chest pain24 (11.4%)22 (11.1%)2 (15.4%).643
 Findings of pneumonia in chest X-ray54 (25.6%)43 (21.7%)11 (84.6%).000*
Comorbidities
 Hypertension13 (6.2%)9 (4.5%)4 (30.8%).000*
 Diabetes4 (1.9%)1 (0.5%)3 (23.1%).000*
 Chronic kidney disease0 (0%)0 (0%)0 (0%).999
 Dyslipidemia6 (2.8%)4 (2.0%)2 (15.4%).005*
Chronic lung disease6 (2.8%)6 (3%)0 (0%).524
Allergic rhinitis9 (4.3%)9 (4.5%)0 (0%).432
Carcinoma1 (0.5%)1 (0.5%)0 (0%).797
Cardiovascular disease2 (0.9%)2 (1.0%)0 (0%).716
  1. p-values were calculated by independent T- or chi-square tests, as appropriate. *Significant difference between groups (p < 0.05). COVID-19: coronavirus disease 2019. Values: mean ± standard deviation